To determine characteristics, management, complications and outcome of neonates with meconium aspiration syndrome (MAS) requiring mechanical ventilation (MV). A retrospective review of clinical data of neonates with MAS who were admitted to a public hospital for MV between January 2004 and December 2006. Eighty-eight neonates were ventilated for MAS. Thirtyone percent were postdates and 51% had no electronic fetal monitoring. Postnatal suctioning of meconium was not performed according to protocol in 47% of nonvigorous infants. High-frequency ventilation and surfactant were used in 32 and 14% of cases, respectively. Persistent pulmonary hypertension of the newborn (PPHN) and pneumothorax occurred in 57 and 24% of cases, respectively. Overall mortality rate was 33%. Neonates suffering from MAS with PPHN had higher mortality rate of 48% compared with 13% in those suffering from MAS without PPHN. Factors associated with mortality were peak inspiratory pressure (P<0.001), pneumothorax (P<0.001) and PPHN (P ¼ 0.001). Postdates, inadequate intrapartum monitoring and limited use of adjunct respiratory therapies were common. Severe MAS is associated with adverse outcome.
Introduction
Meconium aspiration syndrome (MAS) is associated with significant morbidity and mortality. Common complications associated with MAS include interstitial emphysema, pneumothorax, pneumonia and persistent pulmonary hypertension of the newborn (PPHN). Pulmonary air leaks have been observed to occur in 15 to 33% of cases of MAS. 1, 2 Although MAS is still associated with significant mortality, mortality rates seem to have decreased over the years. Studies from 1970s and 1980s reported high mortality rates ranging from 28 to 40%. 3, 4 Recent literature has reported mortality rates less than 15%. 1, 2, 5 This reduction in mortality rates appears to be related (1) to reduction in incidence of MAS, which is related to changes in obstetric practices 6, 7 and (2) to use of adjunct respiratory therapies, such as exogenous surfactant, nitric oxide and high-frequency ventilation in the management of neonates with MAS. [8] [9] [10] Yoder et al. 6 reported that MAS decreased nearly fourfold between 1990 to1992 and 1997 to 1998, and this was associated with 33% reduction in births more than 41 weeks gestation, more frequent diagnosis of nonreassuring fetal heart rate patterns and greater use of amnioinfusion. Approximately 50% of patients with MAS will have severe MAS defined as the need for mechanical ventilation (MV). 11 The reports on the outcome of patients with MAS, especially those who require MV, originate mainly from developed countries. Factors such as poor monitoring during labor and low Apgar scores that are associated with the need for MV among infants with MAS 11 occur commonly in developing countries; therefore, patients with MAS in developing countries might have worse outcomes compared with those from developed countries. Secondly, the adjunct respiratory therapies that have been associated with reduction in mortality are not easily available in developing countries. The limitations of assessing the outcomes of MAS in developing countries are related to limited resources resulting in difficulties in making a diagnosis of MAS, which requires the presence of X-ray changes. In developing countries, patients with possible MAS might die before a chest X-ray (CXR) can be taken or might improve and be discharged without having had a CXR unless they are admitted to the neonatal intensive care unit (NICU) for MV. Therefore, patients who are admitted to NICU are more likely to have CXR. The aim of this study was to describe characteristics, management and outcome of neonates with MAS in a setting where resources are limited. Owing to difficulties in reliably diagnosing MAS in patients who do not require MV, this study was limited to those who required MV.
Methods
Infants with severe MAS were identified by review of discharge diagnoses and hospital records of all patients who weighed X2000 g and were admitted to the NICU of Chris Hani Baragwanath Hospital, Johannesburg, South Africa, between January 2004 and December 2006. Maternal and neonatal hospital charts were reviewed for confirmation of the diagnosis and pertinent clinical data.
Severe MAS was diagnosed if infants met the three following criteria: meconium-stained amniotic fluid (MSAF), need for MV and radiographic abnormalities consistent with MAS ( Figure 1 ).
Patients were excluded from the study if there was no documentation of the presence of MSAF, if records were incomplete, if CXR was not available from records and no comment was present on CXR findings in doctor's notes or if the baby had congenital abnormalities.
During the study period, the protocol on postnatal management of infants born through MSAF was according to the guidelines of the International Liaison Committee on Resuscitation. 12 The guidelines stated that for all infants born through MSAF with absent or depressed respiration, direct laryngoscopy should be conducted immediately after birth for suctioning of residual meconium from the hypopharynx and for intubation and suctioning of the trachea. All patients who were admitted with respiratory distress were started on antibiotics; patients who required MV were started on synchronized intermittent mandatory ventilation using a peak inspiratory pressure of 20 to 25 cm H 2 O, positive end expiratory pressure of 4 to 5 cm H 2 O, inspiratory time of 0.4 s and flow of 5 to 10 l min À1 . There were two models of conventional ventilators used in the unit: the Bear Cub 750PSV infant ventilator and Newport E100M ventilator. The mode of control for the conventional ventilators was pressure limited and time cycled. There were two ventilators available for high-frequency ventilation, both of them were Sensor Medics 3100A oscillatory ventilators. All patients had CXRs ordered immediately postintubation or after insertion of umbilical arterial/venous catheters or when patient deteriorated. Sometimes, there were delays in having X-rays taken especially at night or over the weekends because of staff (radiographers) shortages. Availability of surfactant was limited to 5 vials per month in 2004, and this was increased to 10 vials per month in 2005. Nitric oxide was made available to the unit at the end of 2004. We are limited to use two tanks of nitric oxide per year, with each tank of 10 l containing 900 parts per million of nitric oxide. Both the gas and the delivery and monitoring system were bought from Sidewinder Medical, Cape Town, South Africa. It was only used in patients who had hypoxia thought to be secondary to persistent pulmonary hypertension of the newborn, and it was stopped if there was no response in 60 min. PPHN was diagnosed either with a preductal versus postductal pulse-oximeter oxygen saturation gradient of >10% or on echocardiography.
Demographic characteristics, clinical data and neonatal outcomes to NICU discharge were recorded. Comparison between survivors and nonsurvivors was performed using w 2 or Fisher exact test for categorical variables and Student's t-test for continuous variables. Permission to conduct the study was received from the University of the Witwatersrand Human Research Ethics Committee.
Results

Among the 2157 infants who required MV from January 2004 to
December 2006, 800 weighed X2000 g. Of these 800 infants, 143 had a diagnosis of MAS or had an abnormal CXR with changes suggestive of MAS and were admitted within 48 h of life. Among the 143 patients, 55 were excluded. The reasons for exclusion were absence of a history of MSAF, incomplete hospital records, and therefore inability to confirm or exclude the presence of MSAF, and CXR not found or no comment in patient's file regarding CXR findings ( Figure 2 ). There were 88 patients who had complete records, with history of MSAF in mother's or infant's hospital file, changes on CXR and were ventilated; these were included in the study. These 88 patients accounted for 4% of all admissions requiring MV and 11% of NICU admissions weighing X2000 g. There were 61 399 live births over this 3-year period. The incidence of severe MAS or of infants with MAS requiring MV was 1.43 per 1000 live births.
Characteristics of mothers to infants with MAS are shown in Table 1 . Ninety-eight percent of patients were born inside a healthcare facility and only 2% were born at home. The maternal HIV status was positive in 31% of cases, which was similar to the institutional statistics from antenatal clinic. Thirty-one percent were born at X41 weeks gestation. Electronic monitoring was documented in 49% of cases, of which 78% had abnormal tracing and the common abnormality was late decelerations. Forty-four Figure 1 Chest X-ray representative of X-rays that were selected toward making a diagnosis of meconium aspiration syndrome. percent were born by cesarian section, and the indication for the cesarian section was fetal distress in 90% of cases. Although consistency of MSAF was not recorded in 44% of patients, the majority of them were born through thick meconium.
Infant details are shown in Table 2 . There were 38 (43%) patients who required resuscitation, with almost all of them responding to bag mask ventilation. The number of patients who required resuscitation was greater than those with low Apgar score (score p5) at 1 min, suggesting over-reading of Apgar scores or reflecting our practice of withholding assisted ventilation from infants with the lowest Apgar scores because of concerns about poor neurodevelopmental outcome. Among those who required resuscitation, only 53% were recorded as having been intubated for suctioning of meconium. Severity of the lung disease was moderate to severe in 64% of patients as defined by an oxygen index of more than 10. Twenty-three patients out of the 28 who did not have C-reactive protein (CRP) results are those who died on day 1 of life before CRP level could be done. Among those who had CRP results, 92% had CRP levels more that 10 mg l À1 . Morbidity and mortality of infants with MAS are shown in Table 3 . Common complications among patients with MAS were PPHN (57%) and pneumothorax (24%). Of the 50 patients who The use of exogenous surfactant, number of patients who were put on high-frequency oscillatory ventilation and nitric oxide were low during the study period, and it did not change significantly over the years (P-values all more than 0.100) ( Table 5) . Incidence of pneumothorax, PPHN and mortality rate did not change significantly over the years.
Discussion
Severe MAS is defined as those cases that require assisted MV. 13 It has been reported that between 40 and 50% of infants with MAS will need MV. 11, 14, 15 In public hospitals of developing countries, offering MV is often restricted to those who are expected to have favorable outcomes, and among those who qualify, it is often delayed due to limited bed availability in NICUs. Thus, patients who are ventilated in countries with limited resources are more likely to have poor outcome because of delays in instituting treatment, limited adjunct respiratory therapies and high incidence of having associated conditions such as infections. In this study, we sought to determine characteristics and outcome of infants who were ventilated with MAS, in a setting where there are limited resources. About one-third of patients with severe MAS were born at 41 weeks gestation or more; and 51% of patients were born to mothers who did not have electronic monitoring during labor despite having a history of MSAF. Postmaturity may have contributed to these patients developing MAS. The risk of MAS has been shown to be higher in post-term than term infants with relative risk of 3.1 with 95% confidence interval of 2.6 to 3.7. 16 Inadequate monitoring might have led to delays in expediting delivery of infants who were compromised, and this allowed for ongoing hypoxia resulting in severe disease. The effect of postmaturity and monitoring during pregnancy and labor on MAS is supported by reduction of MAS in institutions where postmaturity has been reduced and monitoring is intensive. 6 The protocol of intubating and suctioning infants suffering from absent or depressed respiration was not followed consistently, as only 53% of infants who should have been intubated according to the protocol were actually intubated. The possible reasons for this low rate of suctioning could be poor documentation of what happens during resuscitation, or that junior doctors who commonly conduct neonatal resuscitation in our hospital were not confident enough to perform intubations and therefore not adhering to protocol. Inadequate suctioning of meconium could have contributed to the development of severe MAS, as it has been reported that meconium in the trachea is one of the major risk factors associated with diagnosis of MAS. 11,17 -20 It is also possible that this did not affect the development of severe MAS, as some studies have suggested that aspiration of meconium occurs in utero and that damage in the lungs has already taken place by the time the baby is born. 1, 19, [21] [22] [23] The high mortality rate of 33% in this study could be related to associated conditions, such as infections and PPHN, and low usage of adjunct respiratory therapies. Among the patients who had their CRP level assessed, 92% had CRP >10 mg l À1 and 78% had CRP >20 mg l À1 , suggesting the presence of infection or inflammation. In vitro studies have suggested that meconium may activate alveolar macrophages with subsequent release of inflammatory cytokines resulting in an increase in CRP. 24 Although only one patient had positive culture, it is difficult to exclude infection when there is abnormal CXR and high CRP. Some studies have reported that clinical chorioamnionitis and neonatal sepsis are more common in neonates with severe MAS. 11, 25, 26 More than 50% of patients in this study had PPHN. Should one exclude or include infants with PPHN when one is looking at outcome of infants with MAS? The literature suggests that these patients should be excluded. The reason for this is that the cause of PPHN in patients with MAS might have preceded the aspiration of meconium. This is supported by findings in autopsies from cases dying from severe MAS within 48 h of birth, which revealed muscularization of distal pulmonary arterioles, which requires 3 to 8 days to develop, making it unlikely that PPHN was a complication of MAS. 23, 27, 28 As PPHN on its own is associated with high mortality rate, one would expect less mortality rate from MAS if infants with PPHN are excluded. In this study, the mortality rate was 73% lower in those with PPHN compared to those without PPHN. The low mortality rate in developed countries has been associated with an increase in the use of exogenous surfactant, high-frequency ventilation and inhaled nitric oxide, with >50% of infants receiving one or more of these therapies. 5 A postal survey of 227 neonatal units in the United Kingdom revealed that 96, 42 and 29% of units were using exogenous surfactant, high-frequency ventilation and inhaled nitric oxide for MAS, respectively. 8 In this study, use of exogenous surfactant, high-frequency ventilation and inhaled nitric oxide ranged from 6 to 19, 21 to 45 and 3 to 6%, respectively, over the 3 years.
In conclusion, patients who were ventilated for MAS were more likely to have been born postdates, to have not been monitored electronically during labor, to have been born by cesarean section and to have not been intubated for suctioning of meconium at birth. MAS requiring MV is still associated with significant morbidity and mortality in the setting where there are limited resources. Reducing patients who deliver post-term, intensive monitoring during labor and offering appropriate neonatal care including exogenous surfactant will improve incidence of MAS and those requiring ventilation, and therefore less strain on already limited resources.
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